Aristotle Capital Boston, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001633911
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 118 positions · Total reported value $1.13B · Top-10 concentration 19.9% · Updated 2026-11-16
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
Turnover: 95.2% · 6 new · 106 cut · 7 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -4.1% · vs SPY -6.2% · Prev Value $1.49B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +6.2% · vs SPY +4.0% · Latest Value $1.13B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, Aristotle Capital Boston, LLC disclosed 118 equity positions with a combined reported value of $1.13B. The filing implies a diversified portfolio: its ten largest positions account for 19.9% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.
The largest disclosed positions as of Q3 2026 were HURN ($29.88M), AER ($25.04M), HAE ($24.68M). By sector, the heaviest allocations are Consumer Discretionary 23.3%, Financials 20.0%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+3.1pp), Health Care (+3.0pp) and away from Industrials (-1.0pp), Energy (-1.0pp).
Versus the prior quarter, Aristotle Capital Boston, LLC opened 6 new positions, trimmed 106 and fully exited 7, a turnover rate of 95.2% of positions. The portfolio's overlap with the prior quarter was 90% of names.
The largest new positions opened in Q3 2026 were USPH ($8.47M), BSY ($7.79M), WFRD ($6.62M).
Of the 7 positions fully exited versus the prior quarter, the largest were EEFT ($15.00M), OII ($9.93M), KN ($7.95M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- USPH U S PHYSICAL THERAPY · $8.47M
- BSY BENTLEY SYS INC · $7.79M
- WFRD WEATHERFORD INTL PLC · $6.62M
- FRPT FRESHPET INC · $5.60M
- TRMB TRIMBLE INC · $1.77M
- CPAY CORPAY INC · $1.72M
Fully Exited (vs previous quarter)
- EEFT EURONET WORLDWIDE INC · prev qtr: $15.00M
- OII OCEANEERING INTL INC · prev qtr: $9.93M
- KN KNOWLES CORP · prev qtr: $7.95M
- SLRC SLR INVESTMENT CORP · prev qtr: $7.59M
- CCRN CROSS CTRY HEALTHCARE INC · prev qtr: $5.91M
- IT GARTNER INC · prev qtr: $697.19K
- WTRG ESSENTIAL UTILS INC · prev qtr: $551.24K
Insider Transactions (Form 4)
Latest Aristotle Capital Boston, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Aristotle Capital Boston, LLC is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 119 US equity positions with a combined value of $1.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-80368 (status: Approved), registered 2014-10-02
- Regulatory AUM (Form ADV): $1.83B as of 2026-03-20
- Client mix (by RAUM): pension and profit-sharing plans 88%, registered investment companies 10%
Portfolio Structure
- 119 positions · $1.49B reported value (Q2 2026)
- Top 10 holdings = 19.7% of reported value
- Largest position: MTSI (MACOM TECH SOLUTIONS HLDGS I) at 2.6%
- Average position size: $12.53M
Sector Tilt
- Financials 21.1%
- Consumer Discretionary 20.1%
- Industrials 16.6%
- (classified holdings cover 97% of value)
Quarterly Activity
- Q2 2026: 2 new, 6 added, 111 reduced, 5 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
190.50K | $29.88M | 2.64% | Reduce | |
| 2 |
|
174.47K | $25.04M | 2.22% | Reduce | |
| 3 |
|
234.39K | $24.68M | 2.18% | Reduce | |
| 4 |
|
675.54K | $24.20M | 2.14% | Reduce | |
| 5 |
|
268.34K | $23.74M | 2.10% | Reduce | |
| 6 |
|
255.03K | $21.99M | 1.95% | Reduce | |
| 7 |
|
222.15K | $19.18M | 1.70% | Reduce | |
| 8 |
|
147.18K | $19.13M | 1.69% | Reduce | |
| 9 |
|
63.24K | $18.66M | 1.65% | Reduce | |
| 10 |
|
35.55K | $17.95M | 1.59% | Reduce | |
| 11 |
|
1.07M | $17.38M | 1.54% | Reduce | |
| 12 |
|
40.85K | $17.31M | 1.53% | Reduce | |
| 13 |
|
108.75K | $17.00M | 1.50% | Add | |
| 14 |
|
520.14K | $16.85M | 1.49% | Reduce | |
| 15 |
|
492.09K | $16.48M | 1.46% | Reduce | |
| 16 |
|
163.16K | $15.42M | 1.36% | Reduce | |
| 17 |
|
389.72K | $15.27M | 1.35% | Reduce | |
| 18 |
|
354.38K | $15.18M | 1.34% | Reduce | |
| 19 |
|
300.68K | $14.95M | 1.32% | Reduce | |
| 20 |
|
179.35K | $14.89M | 1.32% | Reduce | |
| 21 |
|
304.00K | $14.86M | 1.31% | Reduce | |
| 22 |
|
460.10K | $14.63M | 1.29% | Reduce | |
| 23 |
|
571.20K | $14.46M | 1.28% | Reduce | |
| 24 |
|
168.45K | $14.14M | 1.25% | Reduce | |
| 25 |
|
129.35K | $13.96M | 1.24% | Reduce | |
| 26 |
|
187.14K | $13.85M | 1.23% | Reduce | |
| 27 |
|
361.65K | $13.72M | 1.22% | Reduce | |
| 28 |
|
374.09K | $13.40M | 1.19% | Reduce | |
| 29 |
|
47.02K | $13.39M | 1.19% | Reduce | |
| 30 |
|
326.50K | $13.31M | 1.18% | Reduce | |
| 31 |
|
354.76K | $13.28M | 1.18% | Reduce | |
| 32 |
|
71.89K | $12.92M | 1.14% | Reduce | |
| 33 |
|
251.09K | $12.58M | 1.11% | Reduce | |
| 34 |
|
361.51K | $12.56M | 1.11% | Reduce | |
| 35 |
|
194.28K | $12.35M | 1.09% | Reduce | |
| 36 |
|
647.98K | $12.09M | 1.07% | Reduce | |
| 37 |
|
148.53K | $11.93M | 1.06% | Reduce | |
| 38 |
|
276.37K | $11.66M | 1.03% | Reduce | |
| 39 |
|
605.58K | $11.57M | 1.02% | Reduce | |
| 40 |
|
95.07K | $11.52M | 1.02% | Reduce | |
| 41 |
|
74.52K | $11.40M | 1.01% | Reduce | |
| 42 |
|
82.77K | $11.26M | 1.00% | Add | |
| 43 |
|
39.79K | $11.21M | 0.99% | Reduce | |
| 44 |
|
100.72K | $11.18M | 0.99% | Reduce | |
| 45 |
|
367.69K | $11.08M | 0.98% | Reduce | |
| 46 |
|
306.85K | $10.79M | 0.95% | Reduce | |
| 47 |
|
140.34K | $10.26M | 0.91% | Reduce | |
| 48 |
|
229.66K | $10.21M | 0.90% | Reduce | |
| 49 |
|
170.44K | $10.16M | 0.90% | Reduce | |
| 50 |
|
279.48K | $9.99M | 0.88% | Reduce | |
FAQ
What did Aristotle Capital Boston, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, Aristotle Capital Boston, LLC reported 118 equity positions worth $1.13B in aggregate; its largest disclosed positions were HURN ($29.88M), AER ($25.04M), HAE ($24.68M).
How large is Aristotle Capital Boston, LLC's portfolio?
Aristotle Capital Boston, LLC reported $1.13B of long equity holdings across 118 positions as of 2026-Q3. Top-10 holdings account for 19.9% of reported value.
What is Aristotle Capital Boston, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.